Evidence map›Paper›PMID 27097163›Full record

ArticlePLoS neglected tropical diseases2016

Genetic Susceptibility and Predictors of Paradoxical Reactions in Buruli Ulcer.

Yves Thierry Barogui, Sandor-Adrian Klis, Roch Christian Johnson, Richard O Phillips, Eveline van der Veer, Cleo van Diemen, Tjip S van der Werf, Ymkje Stienstra

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease).The Cochrane database of systematic reviews · 2018
    Pooled it
  2. Trial
  3. Clinical and microbiological predictors of healing in Buruli ulcer disease.Journal of clinical tuberculosis and other mycobacterial diseases · 2024
    Article
  4. Article
  5. Observational
  6. Human genetics of Buruli ulcer.Human genetics · 2020
    Review
  7. Human genetics of mycobacterial disease.Mammalian genome : official journal of the International Mammalian Genome Society · 2018
    Review
  8. Review
  9. Buruli Ulcer: a Review of the Current Knowledge.Current tropical medicine reports · 2018
    Review
  10. Article
  11. Article
  12. Susceptibility toFrontiers in microbiology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 4 countries.

Yves Thierry BaroguiCentre de Dépistage et de Traitement de l'Ulcère de Buruli de Lalo, Ministère de la Santé, Cotonou, Bénin.
Sandor-Adrian KlisDepartment of Internal Medicine, Infectious Diseases Service, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Roch Christian JohnsonCentre Interfacultaire de Formation et de Recherche en Environnement pour le Développement Durable, Université d'Abomey-Calavi, Abomey-Calavi, Bénin.
Richard O PhillipsKwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Eveline van der VeerDepartment of Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Cleo van DiemenDepartment of Genetics, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
Tjip S van der WerfDepartment of Internal Medicine, Infectious Diseases Service, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Ymkje StienstraDepartment of Internal Medicine, Infectious Diseases Service, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
University of Groningen · NLKwame Nkrumah University of Science and Technology · GHMinistère de la Santé · TNUniversité d'Abomey-Calavi · BJUniversity Medical Center Groningen · NL

Funding

Medical Research Council MR/J01477X/1
6 · The paper itself

Abstract

introductionBuruli ulcer (BU) is the third most frequent mycobacterial disease in immunocompetent persons after tuberculosis and leprosy. During the last decade, eight weeks of antimicrobial treatment has become the standard of care. This treatment may be accompanied by transient clinical deterioration, known as paradoxical reaction. We investigate the incidence and the risks factors associated with paradoxical reaction in BU.

methodsThe lesion size of participants was assessed by careful palpation and recorded by serial acetate sheet tracings. For every time point, surface area was compared with the previous assessment. All patients received antimicrobial treatment for 8 weeks. Serum concentration of 25-hydroxyvitamin D, the primary indicator of vitamin D status, was determined in duplex for blood samples at baseline by a radioimmunoassay. We genotyped four polymorphisms in the SLC11A1 gene, previously associated with susceptibility to BU. For testing the association of genetic variants with paradoxical responses, we used a binary logistic regression analysis with the occurrence of a paradoxical response as the dependent variable.

resultsParadoxical reaction occurred in 22% of the patients; the reaction was significantly associated with trunk localization (p = .039 by Χ(2)), larger lesions (p = .021 by Χ(2)) and genetic factors. The polymorphisms 3'UTR TGTG ins/ins (OR 7.19, p < .001) had a higher risk for developing paradoxical reaction compared to ins/del or del/del polymorphisms.

conclusionsParadoxical reactions are common in BU. They are associated with trunk localization, larger lesions and polymorphisms in the SLC11A1 gene.

Indexed as

Genetic Predisposition to DiseasePolymorphism, Single NucleotideAnti-Infective AgentsBuruli UlcerCation Transport ProteinsFemaleGenotypeHumansMaleNatural Resistance-associated Macrophage Protein 1RadioimmunoassayRandomized Controlled Trials as TopicTreatment FailureVitamin D25-hydroxyvitamin DAnti-Infective AgentsCation Transport ProteinsNatural Resistance-associated Macrophage Protein 1Vitamin D

Identifiers

PMID27097163
PMCPMC4838240
OpenAlexW2337531779

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.